On August 30, 2025, the Honourable Gao Kaixian, President of the Legislative Assembly of the Macao Special Administrative Region, embarked on a special visit focusing on cutting-edge medical technology in Hengqin. The first stop of this tour was the exhibition hall of the Qin-Ao International Proton and Heavy Ion Hospital. Subsequently, the delegation proceeded to Freelymedical's Hengqin headquarters, where Mr. Zhang Hao, Chairman of Freelymedical International Medical Investment Group, provided a comprehensive accompaniment. President Gao conducted an on-site inspection of the advancements in medical technology within the Greater Bay Area and discussed future collaboration for the integrated development of the healthcare industry between Guangdong and Macao.

First Stop Visit: Focusing on the Bay Area Tumor Hospital, Unlocking a New Future of Precision Treatment

At the exhibition hall of the Qin-Ao International Proton and Heavy Ion Hospital, President Gao Kaixian gained a detailed understanding of the planning, construction, and progress of this specialized tumor hospital in the Bay Area. It is reported that the hospital is led by China Solid Investment (Zhuhai Hengqin) Co., Ltd., with an investment covering over 27,000 square meters. With its core positioning as a "Precision Oncology Medicine Center," the hospital plans to be equipped with internationally advanced multi-room proton and heavy ion therapy systems and establish cancer diagnosis and treatment departments covering the entire care chain, aiming to provide patients with integrated oncology services.

Chairman Zhang Hao introduced on site that "the project has successfully secured a $200 million strategic investment from the Abu Dhabi Royal Capital Group." In the future, the hospital will further integrate global medical resources to build an international benchmark medical platform that combines oncology research, clinical treatment, early screening, and rehabilitation, bringing revolutionary precision treatment solutions to cancer patients in the Bay Area.

Next Stop Investigation: Delving into Freelymedical International, Touching the Forefront Achievements in Cell Technology

1. Integration of Industry, Academia, and Research

Building a Closed-Loop Ecosystem of "Research-Clinical-Industry": Relying on two GMP laboratories—the UM Zhuhai Academy-Freelymedical Joint Laboratory and the Wu Zuzhe Cell Medicine Research Center—and connecting five precision medical centers in locations such as Hengqin and Shanghai, Freelymedical International has established a synergistic development closed-loop system of "research-clinical-industry." This effectively accelerates the translation of cell technology from the laboratory to clinical application.

2. Precision Health Experience

During the inspection, President Gao Kaixian personally experienced the European Doctor comprehensive health assessment system and the One-Drop Blood Suboptimal Health Screening technology. He received real-time in-depth analysis reports on bodily functions, gaining a direct understanding of the efficient health management services enabled by precision medicine.

Dr. Mou Chan, Chief Medical Expert of Freelymedical International, provided an on-site interpretation of "The Science of Cellular Health and Anti-Aging," offering a detailed explanation of the core value of cell technology in enhancing life quality.

3. Innovative Achievements

He experienced Freelymedical International's NAD+ and Placental Membrane Repair Factor products, gaining a detailed understanding of the technological breakthroughs and application prospects of these two products in the fields of cellular metabolic regulation and tissue regeneration. He affirmed their novel value within the precision health sector.

Charting the Future: Guangdong-Macao Collaboration for a "City of Health" in the Bay Area

During the symposium, President Gao Kaixian highly affirmed the outcomes of the two-site inspection. He stated: "From the international layout of the Qin-Ao International Proton and Heavy Ion Hospital to the practical application of cell technology transformation at Freelymedical International, this fully demonstrates the strategic vision of the Hengqin-Guangdong-Macao Deep Cooperation Zone in the biomedical sector. The synergistic development of the two benchmark enterprises, China Solid Investment and Freelymedical International, is a vivid embodiment of Macao's appropriate economic diversification."

Furthermore, President Gao expressed his expectations: "We look forward to both parties continuing to deepen cross-border industry-academia-research collaboration, upgrading medical services through technological innovation, helping Macao build a 'City of Health,' and providing world-leading health solutions for residents of the Greater Bay Area."

President Gao Kaixian's visit not only served as high recognition of Freelymedical International's scientific research capabilities and industrial contributions but also injected new momentum into the synergistic development of healthcare between Guangdong and Macao. In the future, Freelymedical International will continue to uphold its mission of "Using Technology to Guard Life," delving deeper into cutting-edge fields such as cell technology and precision medicine, accelerating the translation of scientific research achievements, and contributing further to the advancement of the Bay Area's health industry and the improvement of public health and well-being.